Amy Siegel is the co-founder of S2N Health, a Boston-based consulting firm advising healthcare technology innovators on business strategy, commercialization planning and market development. Since 2011, S2N has collaborated with more than 70 companies developing new medical devices, diagnostics and drug delivery technologies. Siegel mentors start-up CEOs for MedTech Innovator and MassMEDIC, and publishes a blog on the business of emerging healthcare technology on MassDevice and LinkedIn Pulse. Prior to founding S2N in 2011, she was Vice President of Strategic Marketing at Seventh Sense Biosystems and Aspect Medical Systems, a strategy consultant to global med tech and biopharma companies with Health Advances and Monitor Company, and a loan officer for Asia with the US Export-Import Bank. Siegel earned her B.A. from Tufts University and a Master’s Degree from the Fletcher School of Law & Diplomacy at Tufts.